Evidence map›Paper›PMID 24681602›Full record

ReviewJournal of the National Cancer Institute2014

Challenges and possible solutions to colorectal cancer screening for the underserved.

Samir Gupta, Daniel A Sussman, Chyke A Doubeni, Daniel S Anderson, Lukejohn Day, Amar R Deshpande, B Joseph Elmunzer, Adeyinka O Laiyemo, Jeanette Mendez, Ma Somsouk and 6 more

Registry-linked trialAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of the National Cancer Institute, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03843957 (Effectiveness and Implementation of mPATH-CRC), which is not on this map. Cited by 133 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed, 7 pooled it
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03843957 nacompletednot on this mapstarted 2019, after this paper: background citation

Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening

TypeinterventionalSponsorWake Forest University Health SciencesRan2019 to 2023Enrolled77,145ConditionsColorectal Cancer, Cancer, Rectum Cancer, Colon CancerArmsmPATH-CRC, mPATH-Checkin, "high touch" Implementation strategy, "low touch" Implementation Strategy
3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 7 syntheses or guidelines pooled it, 218 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Pooled it
  7. Pooled it
  8. A Randomized Trial of Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024
    Trial
  9. Trial
  10. Effects of culturally targeted message framing on colorectal cancer screening among African Americans.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2021
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Efficacy of a Telehealth Intervention on Colonoscopy Uptake When Cost Is a Barrier: The Family CARE Cluster Randomized Controlled Trial.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
    Trial
  20. Novel recurrently mutated genes in African American colon cancers.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Trial

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 1 country.

Samir GuptaAffiliations of authors: Division of Gastroenterology, Department of Internal Medicine, University of California San Diego, Veterans Affairs San Diego Healthcare System, San Diego, CA (SG); University of California San Diego Moores Cancer Center, San Diego, CA (SG, MEM); Division of Gastroenterology, Department of Internal Medicine, University of Miami Miller School of Medicine, Miami, FL (DAS, ARD); Department of Family Medicine and Community Health at the Perelman School of Medicine, Center for Clinical Epidemiology and Biostatistics, Leonard Davis Institute for Health Economics, and the Center for Public Health Initiatives, University of Pennsylvania, Philadelphia, PA (CAD); Southern California Kaiser Permanente Group, San Diego, CA (DAS); San Francisco General Hospital; University of California San Francisco, San Francisco, CA (LD, MS, JA); Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, MI (BJE); Division of Gastroenterology, Department of Medicine, Howard University, Washington, DC (AOL); MD Incorporated, Encinitas, CA (JM); Kaiser Northern California Division of Research, Oakland, CA (JA); Alameda County Medical Center, Oakland, CA (TB); University of Texas Southwestern Medical School, Dallas, TX (ZG); Group Health Research Institute, Seattle, WA (BBG); Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY (SHI); Department of Family and Preventive Medicine, University of California San Diego, La Jolla, CA (MEM).
Daniel A Sussman
Chyke A Doubeni
Daniel S Anderson
Lukejohn Day
Amar R Deshpande
B Joseph Elmunzer
Adeyinka O Laiyemo
Jeanette Mendez
Ma Somsouk
James Allison
Taft Bhuket
Zhuo Geng
Beverly B Green
Steven H Itzkowitz
Maria Elena Martinez
University of California, San Francisco · USUniversity of Miami · USAlameda Health System · USCalifornia University of Pennsylvania · USGroup Health Cooperative · USHoward University · USIcahn School of Medicine at Mount Sinai · USPhiladelphia University · USThe University of Texas Southwestern Medical Center · USUniversity of California, San Diego · USUniversity of Michigan–Ann Arbor · USVA San Diego Healthcare System · US

Funding

MICHIGAN INSTITUTE FOR CLINICAL AND HEALTH RESEARCH (MICHR) (UL1): (BPCA)UL1RR024986 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$51.2M
Research Education CoreU54CA132384 · NCI · SAN DIEGO STATE UNIVERSITY · PI CRIPPS, RICHARD MATTHEW, CROWE, SHEILA E. · 2008 to 2022
$20.7M
Resources and Infrastructure: Faculty RecruitmentU54CA091431 · NCI · HOWARD UNIVERSITY · PI ADAMS-CAMPBELL, LUCILE LAUREN · 2001 to 2010
$15.9M
Parkland-UT Southwestern PROSPR Center Colon Cancer Screening in a Safety netU54CA163308 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI SKINNER, CELETTE SUGG · 2011 to 2017
$8.0M
Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-upR01CA121125 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI GREEN, BEVERLY BETH · 2007 to 2017
$8.0M
Effectiveness of Screening Colonoscopy in Reducing Deaths from Colorectal CancerU01CA151736 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DOUBENI, CHYKE ABADAMA · 2011 to 2015
$4.5M
Patient Navigation for CRC Screening with Low-Income MinoritiesR01CA120658 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI REDD, WILLIAM H · 2007 to 2011
$3.3M
Understanding Racial and Ethnic Differences in Survival from Colorectal CancerK01CA127118 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DOUBENI, CHYKE ABADAMA · 2007 to 2011
$773k
HIV, Gut Mucosal Turnover and Inflammation, and the Risk of Colorectal NeoplasiaK23CA157929 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SOMSOUK, MA · 2011 to 2014
$687k
NCI NIH HHS 5U54CA091431-09 S1NCI NIH HHS K01 CA127118NCI NIH HHS K01CA127118NCI NIH HHS K23 CA157929NCI NIH HHS K23CA157929NCI NIH HHS R01 CA120658NCI NIH HHS R01CA120658NCI NIH HHS R01 CA121125NCI NIH HHS U01 CA151736NCI NIH HHS U01-CA151736NCI NIH HHS U54 CA091431NCI NIH HHS U54 CA132384NCI NIH HHS U54CA132384NCI NIH HHS U54 CA163308NCI NIH HHS U54CA163308NCRR NIH HHS UL1 RR024986NCRR NIH HHS UL1RR024986
6 · The paper itself

Abstract

Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. CRC incidence and mortality can be reduced through screening. However, in the United States, screening participation remains suboptimal, particularly among underserved populations such as the uninsured, recent immigrants, and racial/ethnic minority groups. Increasing screening rates among underserved populations will reduce the US burden of CRC. In this commentary focusing on underserved populations, we highlight the public health impact of CRC screening, list key challenges to screening the underserved, and review promising approaches to boost screening rates. We identify four key policy and research priorities to increase screening among underserved populations: 1) actively promote the message, "the best test is the one that gets done"; 2) develop and implement methods to identify unscreened individuals within underserved population groups for screening interventions; 3) develop and implement approaches for organized screening delivery; and 4) fund and enhance programs and policies that provide access to screening, diagnostic follow-up, and CRC treatment for underserved populations. This commentary represents the consensus of a diverse group of experts in cancer control and prevention, epidemiology, gastroenterology, and primary care from across the country who formed the Coalition to Boost Screening among the Underserved in the United States. The group was organized and held its first annual working group meeting in conjunction with the World Endoscopy Organization's annual Colorectal Cancer Screening Committee meeting during Digestive Disease Week 2012 in San Diego, California.

Indexed as

Early Detection of CancerHealthcare DisparitiesMass ScreeningMedically Underserved AreaAdultAgedColonoscopyColorectal NeoplasmsConsensusEmigrants and ImmigrantsFemaleHumansIncidenceMaleMedicaidMedically Uninsured

Identifiers

PMID24681602
PMCPMC3982886
OpenAlexW2109671053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.